Malignant Soft Tissue Neoplasm of Uncertain Differentiation

Malignant Soft Tissue Neoplasm of Uncertain Differentiation — Trials · CancerIndex

Clinical trials

Registered studies

186 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 66
Recruiting: 40
Ph III recruiting: 2
Growth YoY: —
Industry share: 21%
Top sponsor: National Cancer Institute (NCI)
Termination share: 42.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (29)

clinicaltrialsPublishedShowing 1–8 of 8 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04530487	Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young Adults	terminated	Phase 2	1	M.D. Anderson Cancer CenterOTHER	1	Jun 29, 2025	clinicaltrials
NCT03132155	QUILT-3.031: AMG 337 in Subjects With Advanced or Metastatic Clear Cell Sarcoma	terminated	Phase 2	8	NantPharma, LLCINDUSTRY	1	May 24, 2024	clinicaltrials